The use of soft tissue fillers and neurotoxins continues to soar in popularity, and facial plasticsurgeonsare leading the charge when it comes tolayering theseinjectablesto achieve the best possible results.
In 2013, BOTOX® reigned supreme as the most commonly performed non-surgical procedure among women, followed by hyaluronic acid (HA) injections, according to the annual survey of the American Academy of Facial Plastic and Reconstructive Surgery. BOTOX®and HA-based fillers also topped the list of the most popular procedures for men.
“Advanced techniques with fillers and toxins provide patients with a short term alternative to cosmetic surgery, as well as an ideal way to enhance the results of surgical procedures such as facelifts,” said Edward Farrior, MD, FACS, AAFPRS President. “Facial plastic surgeons are using combinations of fillers to safely treat lines and wrinkles, but also to plump and define lips, fill hollow areas on the face and lower eyelids, and lift the cheek area. The results can be subtle or dramatic, depending on the patient’s goals and the fillers used, and can last from six months to several years.”
In addition to the spectrum ofproducts available -including Restylane, Perlane, Sculptra Aesthetics, Radiesse, Juvederm and ArteFill – fat grafting is holding its own as the volumizer of choice for many facial plastic surgeons. The filler pipeline is also robust with several new injectables. Among those expected to receive approval from the Food and Drug Administration (FDA) in the not-too-distant future aretwo more hyaluronic acid gel fillers;Emervel from Galderma and Teosyal from TeoxaneLaboratories. On the toxin side, Revance Therapeutics is on the road to developing the first non-injectable botulinum toxin.
In 2013, we saw two blockbusters earn FDA clearance. The approval ofMerz Aesthetics’ Belotero Balance offered facial plastic surgeons a safe and effective choice for filling in fine lines and areas around the mouth and eyes. Allergan’s Juvederm Voluma ushered in a new era in the filler revolution as the first designer or site-specific filler to hit the US. It volumizes (as the name suggests) the mid face or cheek region. Other designer fillers, some already available in Europe, may also make their way to the US.
The most recent filler to receive the FDA’s nod in 2014 is Restylane Silk for lip plumping and filling lip lines. It includeslidocaine to minimize the stingfrom lip injections.
“The two most popular areas for fillers requested by patients are undoubtedly the nasolabial folds or nose to mouth creases, and the lips. As we age, the lips thin out and the border of the lips tends to flatten and lose their attractive contour. By adding a subtle amount of hyaluronic acid or other substance, we can restore definition and a youthful appearance around the mouth and the lips,” said Edwin Williams, MD, FACS, Group Vice President for Public and Regulatory Affairs for the AAFPRS.
ABOUT THE AAFPRS:
The American Academy of Facial Plastic and Reconstructive Surgery is the world’s largest specialty association for facial plastic surgery. It represents more than 2,700 facial plastic and reconstructive surgeons throughout the world. The AAFPRS is a National Medical Specialty Society of the American Medical Association (AMA), and holds an official seat in both the AMA House of Delegates and the American College of Surgeons board of governors. AAFPRS members are board certified surgeons whose focus is surgery of the face, head, and neck. AAFPRS members subscribe to a code of ethics. The AAFPRS has two humanitarian programs: The FACE TO FACE program offers pro bono facial plastic and reconstructive surgery to domestic violence survivors to repair injuries on the face, head and neck caused by an intimate partner or spouse. FACES OF HONOR connects soldiers injured in the line of duty with facial plastic surgeons who provide pro bono services. The AAFPRS provides consumers with free information and brochures and a list of qualified facial plastic surgeons in any area by visiting the AAFPRS web site, www.aafprs.org.
For more information, or to schedule an interview with an AAFPRS spokesperson, please contact the Academy’s public relations firm, Melissa Kelz Communications at 646-450-5359 // firstname.lastname@example.org and ask to speak to Patty – email@example.com or to Melissa –firstname.lastname@example.org
BOTOX® Cosmetic is a registered trademark owned by Allergan, Inc.
# # #